SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 1,354.04 |
Enterprise Value ($M) | n/a |
Book Value ($M) | 505.36 |
Book Value / Share | 6.94 |
Price / Book | n/a |
NCAV ($M) | -215.60 |
NCAV / Share | -2.96 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.09 |
Return on Assets (ROA) | 0.08 |
Return on Equity (ROE) | 0.17 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.16 |
Current Ratio | 1.86 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 362.56 |
Assets | 1,083.52 |
Liabilities | 578.16 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 871.96 |
Operating Income | 130.70 |
Net Income | 80.55 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 109.89 |
Cash from Investing | -69.74 |
Cash from Financing | -54.01 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
ARDS – Aridis Pharmaceuticals, Inc. | ARGNF – argenx SE |
ARNI – Arno Therapeutics, Inc. | ATHXQ – Athersys, Inc. |
ATRX – Adhera Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io